Decision Diagnostics Corp (DECN)

[Hedgefundstrader]

Exactly. And that is only one part of the outbound strategy. I expect DECN to have many people on the phones and using marketing along with social media to build up the inbound.

There is a very large opportunity here as everyone in the industry including Doctors, healthcare providers, patients, and distributors will embrace this low cost alternative...everyone except Roche, Bayer, Abbott and of course JnJ.